Chronic Immune Thrombocytopenic Purpura—who Needs Medication?

Annals of Hematology - Germany
doi 10.1007/s00277-010-0918-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Immune Thrombocytopenic Purpura and Infections

Internal and Emergency Medicine
Internal MedicineEmergency Medicine
2018English

Long Term Outcome of Splenectomy in Chronic Immune Thrombocytopenic Purpura

International Journal of Hematology Research
2017English

Molecular Mechanisms for Developing Immune Thrombocytopenic Purpura

Japanese Journal of Thrombosis and Hemostasis
2010English

Multiple Myeloma With Concurrent Immune Thrombocytopenic Purpura

ecancermedicalscience
Cancer ResearchOncology
2020English

Chronic Immune Thrombocytopenic Purpura in a Young Female With Rheumatoid Arthritis (Unusual Course)

Case Reports in Clinical Medicine
2018English

PP025 Thrombopoietin Receptor Agonist for Treatment of Adults With Chronic Immune Thrombocytopenic Purpura

International Journal of Technology Assessment in Health Care
Health Policy
2017English

Thrombotic Thrombocytopenic Purpura in Chronic Myelogenous Leukemia

Canadian Journal of Ophthalmology
MedicineOphthalmology
2020English

Coexisting Situs Inversus Totalis and Immune Thrombocytopenic Purpura

Case Reports in Surgery
2016English

Coexistence of Immune Thrombocytopenic Purpura and Polycythemia Vera

Clinical Research and Trials
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy